3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
2
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
3
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
19
Docetaxel
9
atezolizumab
8
Cetuximab
8
Nivolumab
7
cemiplimab
6
Ipilimumab
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Drug Therapy
4
spartalizumab
3
palbociclib
3
fludarabine
3
durvalumab
3
avelumab
3
Trastuzumab
3
Radiotherapy
3
Paclitaxel
3
Oncolytic Virotherapy
3
Irinotecan
3
Fulvestrant
3
Fluorouracil
3
Cyclophosphamide
3
Carboplatin
3
Bortezomib
3
Blood Specimen Collection
3
seribantumab
2
selpercatinib
2
pazopanib
2
motexafin gadolinium
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Tissue Banks
×
Breast
×
Clear all
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled